Stockscreener 앱 받기
28.84
0.10%
+0.03
Genmab ADR 주식(GMAB)의 최신 뉴스
Decoding 9 Analyst Evaluations For Genmab
Benzinga
AbbVie (ABBV) Beats on Q1 Earnings & Sales, Ups '24 EPS View
Zacks Investment Research
Analyst Ratings For Genmab
Benzinga
4 Analysts Assess Genmab: What You Need To Know
Benzinga
Cracking The Code: Understanding Analyst Reviews For Genmab
Benzinga
What's Going On With Danish Healthcare Firm Genmab Stock?
Benzinga
New Strong Buy Stocks for January 17th
Zacks Investment Research
GMAB or TECH: Which Is the Better Value Stock Right Now?
Zacks Investment Research
Oracle Reports Weak Sales, Joins Kinetik, Lucid Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Benzinga
HRMY or GMAB: Which Is the Better Value Stock Right Now?
Zacks Investment Research
AbbVie (ABBV) Lymphoma Drug Gets FDA Breakthrough Therapy Tag
Zacks Investment Research
9 Analysts Have This to Say About Genmab
Benzinga
4.45%
자본화:
|
볼륨(24시간):